Relationship between blood concentrations of hepcidin and anemia severity, mycobacterial burden, and mortality among patients with HIV-associated tuberculosis

Journal of Infectious Diseases

Volumn 213, Issue 1, 2016, Pages 61-70

  Kerkhoff, Andrew D ^a,b,c   Meintjes, Graeme ^c,d,f   Burton, Rosie ^e   Vogt, Monica ^c   Wood, Robin ^c,f   Lawn, Stephen D ^c,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e Khayelitsha Hospital   (South Africa)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

HIV; AIDS; tuberculosis; anemia; hepcidin; antimicrobial; Africa

Indexed keywords

HEPCIDIN;

ADULT; ANEMIA; ARTICLE; BACTERIAL LOAD; DISEASE SEVERITY; FEMALE; HORMONE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIUM; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TUBERCULOSIS; BLOOD; COHORT ANALYSIS; HIV INFECTIONS; MICROBIOLOGY; SOUTH AFRICA; VIROLOGY;

ADULT; ANEMIA; COHORT STUDIES; FEMALE; HEPCIDINS; HIV INFECTIONS; HUMANS; MALE; PROGNOSIS; SOUTH AFRICA; TUBERCULOSIS;

EID: 84961999111     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv364     Document Type: Article

References (45)

1. World Health Organization. Global tuberculosis report 2014. Geneva, Switzerland: 2014. http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809-eng. pdf. Accessed 22 February 2015
2. Kerkhoff AD, Wood R, Vogt M, Lawn SD. Predictive value of anemia for tuberculosis in HIV-infected patients in sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays. J Acquir Immune Defic Syndr 2014; 66: 33-40
3. van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr 2011; 56: 349-55
4. Kerkhoff AD, Wood R, Cobelens FG, Gupta-Wright A, Bekker L-G, Lawn SD. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study. BMC Med 2015; 13: e1001270-24
5. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004; 116: 27-43
6. Morris C, Bird AR, Nell H. The haematological and biochemical changes in severe pulmonary tuberculosis. Q J Med 1989; 73: 1151-9
7. Olaniyi JA, Aken Ova YA. Haematological profile of patients with pulmonary tuberculosis in Ibadan, Nigeria. Afr J Med Sci 2003; 32: 239-42
8. Redig AJ, Berliner N. Pathogenesis and clinical implications of HIV-related anemia in 2013. Hematology Am Soc Hematol Educ Program 2013; 2013: 377-81
9. Volberding P. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis 2002; 185(suppl 2): S110-4
10. Isanaka S, Mugusi F, UrassaW, et al. Iron deficiency and anemia predict mortality in patients with tuberculosis. J Nutr 2012; 142: 350-7
11. Kendon MA, Knight S, Ross A, Giddy J. Timing of antiretroviral therapy initiation in adults with HIV-associated tuberculosis: outcomes of therapy in an urban hospital in KwaZulu-Natal. S Afr Med J 2012; 931-5
12. Minchella PA, Donkor S, Owolabi O, Sutherland JS, McDermid JM. Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions. Clin Infect Dis 2015; 60: 764-72
13. Lee SW, Kang YA, Yoon YS, et al. The prevalence and evolution of anemia associated with tuberculosis. J Korean Med Sci 2006; 21: 1028-32
14. Piperno A, Mariani R, Trombini P, Girella D. Hepcidin modulation in human diseases: from research to clinic. World J Gastroentero 2009; 15: 538
15. Armitage AE, Eddowes LA, Gileadi U, et al. Hepcidin regulation by innate immune and infectious stimuli. Blood 2011; 118: 4129-39
16. Ganz T, Nemeth E. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology Am Soc Hematol Educ Program 2011; 2011: 538-42
17. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23
18. Shin D-M, Jo E-K. Antimicrobial peptides in innate immunity against mycobacteria. Immune Netw 2011; 11: 245
19. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukoc Biol 2007; 82: 934-45
20. Sow FB, Nandakumar S, Velu V, et al. Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis (Edinb) 2011; 91: 314-21
21. Minchella PA, Armitage AE, Darboe B, et al. Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study. Int J Tuberc Lung Dis 2014; 18: 1337-9
22. Wisaksana R, de Mast Q, Alisjahbana B, et al. Inverse relationship of serum hepcidin levels with CD4 cell counts in HIV-infected patients selected from an indonesian prospective cohort study. PLoS One 2013; 8: e79904
23. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012; 12: 201-9
24. Lawn SD, Kerkhoff AD, Burton R, et al. Rapid effective microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission in South Africa by systematic Xpert MTB/RIF testing urine samples: a prospective cohort. BMC Med 2015; In press
25. Lawn SD, Myer L, Bekker L-G, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20: 1605-12
26. Gupta A, Wood R, Kaplan R, Bekker L-G, Lawn SD. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. PLoS One 2013; 8: e55824
27. Lawn SD, Brooks SV, Kranzer K, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 2011; 8: e1001067
28. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whitelaw A, Wood R. Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis 2012; 54: 1071-9
29. Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011; 117: e218-25
30. World Health Organization (WHO). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and mineral nutrition information system. WHO/NMH/NHD/MNM/11.1. Geneva, Switzerland: WHO, 2011. http://www.who.int/vmnis/indicators/haemoglobin.pdf. Accessed 22 February 2015
31. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-54
32. Kerkhoff AD, Wood R, Cobelens FG, Gupta-Wright A, Bekker L-G, Lawn SD. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa. BMC Infect Dis 2014; 14: 702
33. Traoré HN, Meyer D. The effect of iron overload on in vitro HIV-1 infection. J Clin Virol 2004; 31: 92-8
34. Nekhai S, Kumari N, Dhawan S. Role of cellular iron and oxygen in the regulation of HIV-1 infection. Future Virol 2013; 8: 301-11
35. Xu M, Kashanchi F, Foster A, et al. Hepcidin induces HIV-1 transcription inhibited by ferroportin. Retrovirology 2010; 7: 104
36. Gibellini D, Clo A, Morini S, Miserocchi A, Ponti C, Re MC. Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol 2013; 2: 91-101
37. Kaplan M, Erikci AA, Ozturk A, et al. Serum prohepcidin in pulmonary tuberculosis. Hematology 2009; 14: 245-8
38. Lawn SD, Pisell TL, Hirsch CS, Wu M, Butera ST, Toossi Z. Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection. J Infect Dis 2001; 184: 1127-33
39. Brighenti S, Andersson J. Local immune responses in human tuberculosis: learning from the site of infection. J Infect Dis 2012; 205: S316-24
40. Minchella PA, Armitage AE, Darboe B, et al. Elevated hepcidin concentrations at HIV diagnosis are associated with increased mortality [abstract MOLBPE08]. Presented at: 7th IAS Conference on HIV Pathogenesis and Treatment, Kuala Lumpur, Malaysia, 30 June-3 July 2014
41. Hara M, Ando M, Tsuchiya K, Nitta K. Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma. Ann of Hematol 2015; 94: 603-8
42. van Der Weerd NC, Grooteman MPC, Bots ML, et al. Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients. Nephrol Dial Transplant 2013; 28: 3062-71
43. Reyn Von CF, Kimambo S, Mtei L, et al. Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality. Int J Tuberc Lung Dis 2011; 15: 1087-92
44. Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 13: 349-61
45. Nordin G, Samuelsson I, Andersson B, Börjeson J. C-reactive protein: the difference between quantitation in serum and EDTA plasma. Scand J Clin Lab Invest 1996; 56: 123-7